Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Omar Yumen"'
Publikováno v:
Medical Dosimetry. 39:286-291
The aim of the study was to investigate the differences between intraoperative and postoperative dosimetry for transrectal ultrasound-guided transperineal prostate implants using cesium-131 ((131)Cs). Between 2006 and 2010, 166 patients implanted wit
Autor:
Rita Axelrod, Christine H. Chung, Adel K. El-Naggar, Allen M. Chen, Andy Trotti, Jonathan Harris, Q. Zhang, Dörthe Schaue, Chance Matthiesen, V. Avizonis, Phuc Felix Nguyen-Tan, David Raben, Anurag K. Singh, Omar Yumen, Joanne B. Weidhaas, Thomas J. Galloway, Heath D. Skinner, David Sidransky, Robert L. Ferris, R.K. Chin, Demin Wang, R. Manon, James Sayre
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 96:941-942
Autor:
Vivek Khandelwal, Albert M. Bernath, Nava Siegelmann-Danieli, Jeffrey W. Prichard, Timothy J. Murphy, G. Craig Wood, Roshan Mainali, James F. Evans, Omar Yumen
Publikováno v:
Clinical Breast Cancer. 7:59-66
The current work assessed the independent contributions of age, comorbidities, tumor features, and treatment approach to the outcome of elderly patients with breast cancer.Records of consecutive women agedor = 70 years with a histologic diagnosis of
Autor:
Joanne B. Weidhaas, Thomas J. Galloway, Qiang Zhang, Christine H. Chung, Rafael R. Manon, Andy Trotti, David Sidransky, David Raben, Jonathan Harris, Rita Axelrod, Dörthe Schaue, Dian Wang, Chance Matthiesen, Robert Chin, Allen M. Chen, Anurag K. Singh, Vilija N. Avizonis, Robert L. Ferris, Phuc Felix Nguyen-Tan, Omar Yumen, Heath D. Skinner, Adel K. El-Naggar
Publikováno v:
JAMA oncology, vol 3, iss 4
Importance There is a significant need to find biomarkers of response to radiotherapy and cetuximab in locally advanced head and neck squamous cell carcinoma (HNSCC) and biomarkers that predict altered immunity, thereby enabling personalized treatmen
Publikováno v:
International journal of radiation oncology, biology, physics. 69(5)
Purpose To report long-term data from a prospective trial of subcutaneous (s.c.) amifostine in patients who received chemoradiotherapy for squamous cell carcinoma of the head and neck (SCCHN). Methods and Materials Patients ≥18 years of age with pr
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 81:S246-S247
Autor:
Christine H. Chung, Terence S. Herman, Rita Axelrod, Dian Wang, R. Manon, Qiang Zhang, Omar Yumen, R. Jeffrey Lee, Joanne B. Weidhaas, Thomas J. Galloway, Anurag K. Singh, David Raben, Adel K. El-Naggar, Jonathan Harris
Publikováno v:
Journal of Clinical Oncology. 32:6000-6000
6000 Background: The KRAS-variant, a germ-line mutation in a microRNA-binding site in KRAS, predicts increased cancer risk and unique cancer biology for many cancers. RTOG 0522 is a phase III trial...
Publikováno v:
Brachytherapy. 9:S98
Publikováno v:
American journal of clinical pathology. 96(3)
Heparin-associated thrombocytopenia with thrombosis (HATT) is an uncommon syndrome that is estimated to occur in 1-5% of patients with heparin-induced thrombocytopenia. Early diagnosis requires careful clinical surveillance, and the management of the
Publikováno v:
Brachytherapy. 7:194